Yamaguchi, Japan

Yukimi Sakoda

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yukimi Sakoda

Introduction

Yukimi Sakoda is a prominent inventor based in Yamaguchi, Japan. She has made significant strides in the field of immunotherapy, particularly through her innovative work on antibodies and immunocompetent cells. With a total of eight patents to her name, her contributions are paving the way for advancements in cancer treatment.

Latest Patents

Sakoda's latest patents include the development of an anti-GPC3 antibody that recognizes a unique epitope, distinct from existing antibodies such as GC33 and GC199. This antibody can specifically bind to GPC3 localized on cell membranes, even in the form of a single chain antibody. Additionally, she has developed a CAR (Chimeric Antigen Receptor) that incorporates this anti-GPC3 single chain antibody, along with immunocompetent cells expressing the CAR. Her work also includes methods for specifically detecting GPC3 and kits designed for this purpose. Furthermore, she has created immunocompetent cells that express regulatory factors of immune function, which possess proliferative potential and the ability to accumulate T cells. These innovations are crucial for enhancing cancer immunotherapy.

Career Highlights

Sakoda has had a distinguished career, working at esteemed institutions such as Yamaguchi University and the National Cancer Center. Her research has focused on the intersection of immunology and cancer treatment, leading to groundbreaking discoveries that have the potential to improve patient outcomes.

Collaborations

Throughout her career, Sakoda has collaborated with notable colleagues, including Koji Tamada and Keishi Adachi. These partnerships have fostered a collaborative environment that has been instrumental in advancing her research and innovations.

Conclusion

Yukimi Sakoda's contributions to the field of immunotherapy through her innovative patents and collaborative efforts highlight her as a leading figure in cancer research. Her work continues to inspire advancements that may significantly impact the future of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…